Integrated Advisors Network’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$371K Sell
2,195
-568
-21% -$97.1K 0.02% 515
2025
Q4
$466K Buy
+2,763
New +$449K 0.02% 491
2024
Q4
Sell
-1,919
Closed -$279K 730
2024
Q3
$279K Sell
1,919
-450
-19% -$65.1K 0.01% 619
2024
Q2
$325K Sell
2,369
-350
-13% -$46.7K 0.02% 547
2024
Q1
$373K Buy
+2,719
New +$371K 0.02% 541
2023
Q3
Sell
-1,694
Closed -$215K 681
2023
Q2
$215K Buy
1,694
+1
+0.1% +$130 0.01% 619
2023
Q1
$219K Sell
1,693
-4
-0.2% -$524 0.01% 611
2022
Q4
$223K Sell
1,697
-188
-10% -$24.3K 0.01% 570
2022
Q3
$220K Sell
1,885
-801
-30% -$99.5K 0.01% 576
2022
Q2
$316K Buy
+2,686
New +$319K 0.02% 514
2022
Q1
Sell
-6,375
Closed -$973K 681
2021
Q4
$973K Sell
6,375
-720
-10% -$111K 0.06% 291
2021
Q3
$1.15M Sell
7,095
-4,519
-39% -$760K 0.08% 234
2021
Q2
$1.9M Buy
11,614
+1,813
+18% +$279K 0.14% 162
2021
Q1
$1.48M Buy
9,801
+2,203
+29% +$350K 0.13% 164
2020
Q4
$1.15M Buy
7,598
+279
+4% +$39.9K 0.13% 180
2020
Q3
$991K Sell
7,319
-278
-4% -$37.7K 0.13% 179
2020
Q2
$1.04M Sell
7,597
-373
-5% -$47.5K 0.12% 179
2020
Q1
$859K Sell
7,970
-222
-3% -$25.6K 0.17% 145
2019
Q4
$987K Buy
+8,192
New +$914K 0.13% 179

Other funds holding IBB

Integrated Advisors Network's IBB Position: Q1 2026 in Review

Integrated Advisors Network reduced its iShares Biotechnology ETF (IBB) stake by 21% in Q1 2026, selling an estimated $97.1K and leaving 2,195 shares worth $371K. The position accounts for 0.02% of the portfolio, ranked #515.

Integrated Advisors Network first reported a position in IBB in Q4 2019 and has held it in 19 quarters since. The position peaked at $1.9M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Integrated Advisors Network held 2,195 shares of iShares Biotechnology ETF worth $371K as of Q1 2026.
  • Integrated Advisors Network sold 568 iShares Biotechnology ETF shares in Q1 2026, an estimated $97.1K.
  • iShares Biotechnology ETF made up 0.02% of Integrated Advisors Network's portfolio in Q1 2026, its #515 holding.
  • Integrated Advisors Network first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 19 quarters since.
  • Integrated Advisors Network's iShares Biotechnology ETF position peaked at $1.9M in Q2 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Integrated Advisors Network's 13F filing for Q1 2026, filed 28 Apr 2026.